drugset
drugset / Trial / NCT04555798

Effect of Arterio-venous ECMO on Severe Sepsis and ARDS

NCT04555798 ↗

Phase 1/2 Completed 100 enrolled Mohamed Gaber Allam King Abdul Aziz Specialist Hospital · collab
RandomizedParallel-groupSingle-blindScreening

Summary

To evaluate and compare the effect of immunoadsorption effect of A-V ECMO on course of sepsis weaning from inotropes, weaning from the ventilator, duration of ICU stays and effect on mortality rate in patients with septic shock and respiratory failure due to ARDS followed severe lung contusion.

Timeline

Start
2022-02-01
Primary completion
2022-02-01
Completion
2022-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Meropenem Small molecule 1 g —

Indications

respiratory failure